Quadriplegia Treatment Market Size

  • Report ID: 3951
  • Published Date: May 07, 2024
  • Report Format: PDF, PPT

Quadriplegia Treatment Market Size

Quadriplegia Treatment Market size is poised to reach USD 4 Billion by the end of 2036, growing at a CAGR of 5% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of quadriplegia treatment was USD 2 Billion. The reason behind the growth is impelled by an increasing incidence of spinal cord injuries across the world. A spinal cord injury can result in loss of function or mobility, which can lead to quadriplegia or tetraplegia, as well as loss of muscle strength. For instance, more than 55% of severe spinal cord injury instances result in quadriplegia, making it the most prevalent symptom overall.

According to the World Health Organization (WHO), between 250,000 to 500,000 persons worldwide are affected by spinal cord injuries (SCI) each year.

The growing advancement in the field of quadriplegia treatment is believed to fuel the quadriplegia treatment market growth. For instance, researchers from Northwestern University researchers have devised a new injectable therapy that uses "dancing molecules" to mend spinal cord lesions, which gives hope to thousands of people affected annually who suffer serious spinal cord injuries and become paralyzed.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3951
  • Published Date: May 07, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing incidence of spinal cord injuries across the world and the growing advancement in the field of quadriplegia treatment are the major factors driving the growth of the market.

The market size of quadriplegia treatment is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.

The major players in the market are Sanofi SA, AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Bristol Myers Squibb Company, and others.

The hospital pharmacies segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample